Biocon Limited has informed the Exchange regarding a press release dated May 24, 2024, titled "Biocon Limited signs exclusive licensing and supply deal for the commercialization of Liraglutide in South Korea with Handok Inc.".
Press Release May 24 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Press Release May 21 2024
- Press Release May 16 2024
- Press Release May 13 2024
- Press Release Apr 17 2024
- Press Release Mar 27 2024
Later from Biocon
- Press Release Aug 08 2024
- Biocon Limited Press Release Aug 29 2024
- Press Release Sep 25 2024
- Press Release Sep 26 2024
- Biocon Limited partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 products in the Middle East region
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon